Reports

Bacteria-Based Cancer Therapies: A Revolutionary Approach Gaining Ground

• By Newsdesk
• Cambridge
• Mar 21, 2025

Reports

The concept of using bacteria to combat cancer is gaining renewed interest, with scientists making significant breakthroughs in harnessing these microorganisms to target and destroy tumor cells. What was once considered an unconventional and risky method is now showing promise as a potentially transformative cancer treatment.

A Historical Perspective

The use of bacteria in cancer therapy is not a novel idea. In the 1860s, Dr. William B. Coley, often referred to as the father of immunotherapy, injected a cancer patient with streptococcal bacteria. This experimental treatment surprisingly led to tumor shrinkage, laying the groundwork for bacteria-based immunotherapy. Over the following decades, Coley treated more than a thousand cancer patients with his bacterial concoction, known as Coley’s toxins.

Despite some successes, the development of radiation and chemotherapy eclipsed interest in bacterial therapies. Skepticism from the medical community further hindered progress. However, modern immunology has reignited interest in Coley’s pioneering work, providing a deeper understanding of how bacteria can stimulate immune responses against cancer.

How Bacteria-Based Cancer Therapies Work

Certain bacteria possess a unique ability to thrive in the tumor microenvironment, which is characterized by low oxygen levels, acidity, and necrotic tissue. Once inside the tumor, these bacteria can directly destroy cancer cells or stimulate the immune system to launch an attack against them.

Researchers are leveraging genetic engineering to create bacteria that can produce and deliver anti-cancer agents directly to tumors. This targeted approach aims to minimize damage to healthy cells and reduce side effects commonly associated with conventional treatments.

However, introducing live bacteria into the body presents safety concerns. Scientists are addressing this by weakening bacterial strains to ensure they remain harmless to healthy tissues. Additionally, they are developing strategies to control bacterial proliferation and prevent unintended spread.

Recent Advances in Bacteria-Based Therapies

Recent advancements in synthetic biology and genetic engineering have propelled bacterial cancer therapies forward. Scientists can now program bacteria to perform specific functions, such as releasing therapeutic molecules or activating immune responses within tumors.

For example, researchers have engineered strains of E. coli to deliver tumor-specific antigens to immune cells, effectively training them to recognize and eliminate cancer cells. In preclinical trials involving laboratory animals, this approach has led to significant tumor shrinkage and, in some cases, complete remission.

Emerging studies suggest that bacteria-based therapies could be particularly effective against solid tumors with poor blood supply, which often resist traditional treatments. Cancers like colorectal, ovarian, and metastatic breast cancer are among the primary targets for these experimental therapies.

Furthermore, bacterial therapies are showing promise when combined with existing immunotherapy drugs. By enhancing immune responses, these treatments may improve the efficacy of immune checkpoint inhibitors and other cancer immunotherapies.

Looking Ahead: Challenges and Opportunities

While the potential of bacteria-based cancer therapies is evident, numerous challenges remain. Scientists are working to optimize bacterial strains for maximum therapeutic effect while minimizing side effects. Dosage determination and the management of bacterial interactions with the body’s microbiome are also areas of ongoing research.

Clinical trials will be crucial in determining the safety and effectiveness of these therapies in humans. Early-phase trials have shown promising results, but larger, more comprehensive studies are needed to assess long-term outcomes and establish standardized treatment protocols.

The resurgence of interest in bacteria-based cancer therapies represents a remarkable convergence of historical insight and modern scientific innovation. As research progresses, these therapies have the potential to become a powerful addition to the arsenal of cancer treatments, offering new hope to patients worldwide.

(With inputs from PTI)